CompletedNCT01272531
Genes Linked to Mood-Stabilizer Response in Bipolarity
About this title
Read the official source — NCT01272531Observational studyAges 18+Multiple countries
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- San Diego and 9 more locationsSee all locations and recruitment
Study information
Study start dateStarted: April 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 560
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- United States, Canada, Norway
- Age range
- Over 18 Years
- Official registry ID
- NCT01272531
- Official title
Show the full official title
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Diego, United States · Chicago, United States · Indianapolis, United States
7 more locations
- Iowa City, United States
- Baltimore, United States
- Ann Arbor, United States
- Cleveland, United States
- Philadelphia, United States
- Halifax, Canada
- Bergen, Norway
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Did this study involve medication?
Yes. The study involved medication, including Mood stabilizer treatment.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
